ibrutinib

Details

Files

Generic Name:

ibrutinib

Project Status:

Received

Therapeutic Area:

Hematology

Call for patient/clinician input open:

March 6, 2025

Brand Name:

N/A

Project Line:

Reimbursement Review

Project Number:

PX0380-000

Call for patient/clinician input closed:

April 29, 2025

Submission Type:

Non-sponsored Submission

Indications:

In combination with immunochemotherapy with or without autologous stem-cell transplantation (ASCT) for previously untreated transplant-eligible patients with mantle cell lymphoma (MCL)

Files

Proposed Scope View PDF

Last Updated : March 6, 2025